Katarzyna Owczarek

Mrs. Katarzyna Owczarek

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
AMAleksandra Milewska
Aleksandra Milewska
PNPaulina Nowak
Paulina Nowak
KOKatarzyna Owczarek
Katarzyna Owczarek
ASArtur Szczepański
Artur Szczepański
MZMiroslaw Zarebski
Miroslaw Zarebski
KPKrzysztof Pyrc
Krzysztof Pyrc
The first steps of human coronavirus NL63 (HCoV-NL63) infection were previously described. The virus binds to target cells by use of heparan sulfate proteoglycans and interacts with the ACE2 protein. Subsequent events, including virus internalization and trafficking, remain to be elucidated. In this study, we mapped the process of HCoV-NL63 entry into the LLC-Mk2 cell line and ex vivo three-dimensional (3D) tracheobronchial tissue. Using a variety of techniques, we have shown that HCoV-NL63 virions require endocytosis for successful entry into the LLC-MK2 cells, and interaction between the virus and the ACE2 molecule triggers recruitment of clathrin. Subsequent vesicle scission by dynamin results in virus internalization, and the newly formed vesicle passes the actin cortex, which requires active cytoskeleton rearrangement. Finally, acidification of the endosomal microenvironment is required for successful fusion and release of the viral genome into the cytoplasm. For 3D tracheobronchial tissue cultures, we also observed that the virus enters the cell by clathrin-mediated endocytosis, but we obtained results suggesting that this pathway may be bypassed. IMPORTANCE Available data on coronavirus entry frequently originate from studies employing immortalized cell lines or undifferentiated cells. Here, using the most advanced 3D tissue culture system mimicking the epithelium of conductive airways, we systematically mapped HCoV-NL63 entry into susceptible cells. The data obtained allow for a better understanding of the infection process and may support development of novel treatment strategies.

8 May 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KOKatarzyna Owczarek
Katarzyna Owczarek
ASArtur Szczepański
Artur Szczepański
AMAleksandra Milewska
Aleksandra Milewska
Zbigniew BasterZbigniew Baster
Zbigniew Baster
ZRZenon Rajfur
Zenon Rajfur
KPKrzysztof Pyrc
Krzysztof Pyrc
The Coronaviridae family clusters a number of large RNA viruses, which share several structural and functional features. However, members of this family recognize different cellular receptors and exploit different entry routes, what affects their species specificity and virulence. The aim of this study was to determine how human coronavirus OC43 enters the susceptible cell. Using confocal microscopy and molecular biology tools we visualized early events during infection. We found that the virus employs caveolin-1 dependent endocytosis for the entry and the scission of virus-containing vesicles from the cell surface is dynamin-dependent. Furthermore, the vesicle internalization process requires actin cytoskeleton rearrangements. With our research we strove to broaden the understanding of the infection process, which in future may be beneficial for the development of a potential therapeutics.

5 April 2019 in Viruses
Verified
Journal Article
Open access
PDF file
ASArtur Szczepański
Artur Szczepański
KOKatarzyna Owczarek
Katarzyna Owczarek
MBMonika Bzowska
Monika Bzowska
KGKatarzyna Gula
Katarzyna Gula
IDInga Drebot
Inga Drebot
KPKrzysztof Pyrc
Krzysztof Pyrc
Despite high similarity of canine respiratory coronavirus (CRCoV), bovine coronavirus, (BCoV) and human coronavirus OC43 (HCoV-OC43), these viruses differ in species specificity. For years it was believed that they share receptor specificity, utilizing sialic acids for cell surface attachment, internalization, and entry. Interestingly, careful literature analysis shows that viruses indeed bind to the cell surface via sialic acids, but there is no solid data that these moieties mediate virus entry. In our study, using a number of techniques, we showed that all three viruses are indeed able to bind to sialic acids to a different extent, but these molecules render the cells permissive only for the clinical strain of HCoV-OC43, while for others they serve only as attachment receptors. CRCoV and BCoV appear to employ human leukocyte antigen class I (HLA-1) as the entry receptor. Furthermore, we identified heparan sulfate as an alternative attachment factor, but this may be related to the cell culture adaptation, as in ex vivo conditions, it does not seem to play a significant role. Summarizing, we delineated early events during CRCoV, BCoV, and HCoV-OC43 entry and systematically studied the attachment and entry receptor utilized by these viruses.

1 June 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAleksandra Milewska
Aleksandra Milewska
KKKamil Kaminski
Kamil Kaminski
JCJustyna Ciejka
Justyna Ciejka
KOKatarzyna Owczarek
Katarzyna Owczarek
SZSlawomir Zeglen
Slawomir Zeglen
KPKrzysztof Pyrc
Krzysztof Pyrc
To date, six human coronaviruses have been known, all of which are associated with respiratory infections in humans. With the exception of the highly pathogenic SARS and MERS coronaviruses, human coronaviruses (HCoV-NL63, HCoV-OC43, HCoV-229E, and HCoV-HKU1) circulate worldwide and typically cause the common cold. In most cases, infection with these viruses does not lead to severe disease, although acute infections in infants, the elderly, and immunocompromised patients may progress to severe disease requiring hospitalization. Importantly, no drugs against human coronaviruses exist, and only supportive therapy is available. Previously, we proposed the cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride (HTCC), and its hydrophobically-modified derivative (HM-HTCC) as potent inhibitors of the coronavirus HCoV-NL63. Here, we show that HTCC inhibits interaction of a virus with its receptor and thus blocks the entry. Further, we demonstrate that HTCC polymers with different degrees of substitution act as effective inhibitors of all low-pathogenic human coronaviruses.

10 December 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
KPKatarzyna Wanda Pancer
Katarzyna Wanda Pancer
AMAleksandra Milewska
Aleksandra Milewska
KOKatarzyna Owczarek
Katarzyna Owczarek
ADAgnieszka Dąbrowska
Agnieszka Dąbrowska
MKMichał Bożydar Kowalski
Michał Bożydar Kowalski
KPKrzysztof Pyrc
Krzysztof Pyrc
SARS-CoV-2 genome annotation revealed the presence of 10 open reading frames (ORFs), of which the last one (ORF10) is positioned downstream of the N gene. It is a hypothetical gene, which was speculated to encode a 38 aa protein. This hypothetical protein does not share sequence similarity with any other known protein and cannot be associated with a function. While the role of this ORF10 was proposed, there is growing evidence showing that the ORF10 is not a coding region. Here, we identified SARS-CoV-2 variants in which the ORF10 gene was prematurely terminated. The disease was not attenuated, and the transmissibility between humans was maintained. Also, in vitro, the strains replicated similarly to the related viruses with the intact ORF10. Altogether, based on clinical observation and laboratory analyses, it appears that the ORF10 protein is not essential in humans. This observation further proves that the ORF10 should not be treated as the protein-coding gene, and the genome annotations should be amended.

26 March 2025 in Nature
Verified
Journal Article
Open access
PDF file
MLManon Laporte
Manon Laporte
DJDIRK JOCHMANS
DIRK JOCHMANS
DBDorothée Bardiot
Dorothée Bardiot
LDLowiese Desmarets
Lowiese Desmarets
ODOliver J. Debski-Antoniak
Oliver J. Debski-Antoniak
JNJohan Hendrik Neyts
Johan Hendrik Neyts
The coronavirus membrane protein (M) is the main organizer of coronavirus assembly1,2,3. Here, we report on an M-targeting molecule, CIM-834, that blocks the assembly of SARS-CoV-2. CIM-834 was obtained through high-throughput phenotypic antiviral screening followed by medicinal-chemistry efforts and target elucidation. CIM-834 inhibits the replication of SARS-CoV-2 (including a broad panel of variants) and SARS-CoV. In SCID mice and Syrian hamsters intranasally infected with SARS-CoV-2, oral treatment reduced lung viral titres to nearly undetectable levels, even (as shown in mice) when treatment was delayed until 24 h before the end point. Treatment of infected hamsters prevented transmission to untreated sentinels. Transmission electron microscopy studies show that virion assembly is completely absent in cells treated with CIM-834. Single-particle cryo-electron microscopy reveals that CIM-834 binds and stabilizes the M protein in its short form, thereby preventing the conformational switch to the long form, which is required for successful particle assembly. In conclusion, we have discovered a new druggable target in the replication cycle of coronaviruses and a small molecule that potently inhibits it.